News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Meyers Pete A.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/27/2020 |
4
| Meyers Pete A. (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 1,653 shares
@ $57.98, valued at
$95.8k
|
|
| 01/07/2020 |
4
| Meyers Pete A. (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 19,500 shares
@ $0
Paid exercise price by delivering 632 shares
@ $57.38, valued at
$36.3k
Granted 48,000 options to buy
@ $59.795, valued at
$2.9M
|
|
| 01/25/2019 |
4
| Meyers Pete A. (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 600 shares
@ $41.33, valued at
$24.8k
Granted 19,300 shares
@ $0
Granted 43,200 options to buy
@ $42.4, valued at
$1.8M
|
|
| 01/09/2018 |
4
| Meyers Pete A. (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 7,000 shares
@ $0
Granted 37,000 options to buy
@ $59.14, valued at
$2.2M
Granted 21,000 rights
@ $0 |
|
| 08/16/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/15/2017 |
4
| Meyers Pete A. (CFO) has filed a Form 4 on EAGLE PHARMACEUTICALS, INC.|
Txns:
| Granted 50,000 options to buy
@ $82.3, valued at
$4.1M
|
|
| 05/15/2017 |
3
| Meyers Pete A. (CFO) has filed a Form 3 on EAGLE PHARMACEUTICALS, INC. |
|
|